Iroquois Capital Management, LLC 13D and 13G filings for Petros Pharmaceuticals, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
| 2025-05-15 10:15 am Purchase |
2025-03-31 | 13G | Petros Pharmaceuticals, Inc. PTPI |
Iroquois Capital Management, LLC | 5,939,954 9.990% |
5,838,871 (+5776.29%) |
Filing |
| 2025-02-26 09:16 am Purchase |
2025-02-17 | 13G | Petros Pharmaceuticals, Inc. PTPI |
Iroquois Capital Management, LLC | 101,083 9.990% |
101,083 (New Position) |
Filing |